Known targets — ChEMBL curated mechanism
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
The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIN2D | O15399 | 1/20 | 0.64 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.64 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.64 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.64 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.64 |
| ▸ | GABRP | O00591 | 4/20 | 0.63 |
| ▸ | GABRD | O14764 | 4/20 | 0.63 |
| ▸ | GABRA1 | P14867 | 4/20 | 0.63 |
| ▸ | GABRB1 | P18505 | 4/20 | 0.63 |
| ▸ | GABRG2 | P18507 | 4/20 | 0.63 |
| ▸ | GABRB3 | P28472 | 4/20 | 0.63 |
| ▸ | GABRA5 | P31644 | 4/20 | 0.63 |
| ▸ | GABRA3 | P34903 | 4/20 | 0.63 |
| ▸ | GABRA2 | P47869 | 4/20 | 0.63 |
| ▸ | GABRB2 | P47870 | 4/20 | 0.63 |
| ▸ | GABRA4 | P48169 | 4/20 | 0.63 |
| ▸ | GABRE | P78334 | 4/20 | 0.63 |
| ▸ | GABRA6 | Q16445 | 4/20 | 0.63 |
| ▸ | GABRG1 | Q8N1C3 | 4/20 | 0.63 |
| ▸ | GABRG3 | Q99928 | 4/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12178194 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL10308278 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL4557360 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL18610325 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL22451788 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL23872369 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL7300704 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL3049001 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL598324 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 | |
| SCHEMBL13012758 | 0.95 | GABRA1 (0.69) | GABRPGABRDGABRA1GABRB1GABRG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119950517-A | Ganaxolone for the treatment of tuberous sclerosis | 马瑞纳斯制药公司 | 2025-05-09 | — | — | CN | disclosed |
| CN-114828889-B | Ganaxolone for the treatment of tuberous sclerosis | 马瑞纳斯制药公司 | 2025-02-14 | — | — | CN | disclosed |